These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 37149835)
1. Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes. Fodder K; Murthy M; Rizzu P; Toomey CE; Hasan R; Humphrey J; Raj T; Lunnon K; Mill J; Heutink P; Lashley T; Bettencourt C Acta Neuropathol; 2023 Jul; 146(1):77-95. PubMed ID: 37149835 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological correlations in behavioural variant frontotemporal dementia. Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic Age Acceleration in Frontotemporal Lobar Degeneration: A Comprehensive Analysis in the Blood and Brain. Murthy M; Rizzu P; Heutink P; Mill J; Lashley T; Bettencourt C Cells; 2023 Jul; 12(14):. PubMed ID: 37508584 [TBL] [Abstract][Full Text] [Related]
4. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration. Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939 [TBL] [Abstract][Full Text] [Related]
5. Plasma proteome profiling identifies changes associated to AD but not to FTD. Mofrad RB; Del Campo M; Peeters CFW; Meeter LHH; Seelaar H; Koel-Simmelink M; Ramakers IHGB; Middelkoop HAM; De Deyn PP; Claassen JAHR; van Swieten JC; Bridel C; Hoozemans JJM; Scheltens P; van der Flier WM; Pijnenburg YAL; Teunissen CE Acta Neuropathol Commun; 2022 Oct; 10(1):148. PubMed ID: 36273219 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid. Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647 [TBL] [Abstract][Full Text] [Related]
7. Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration. Bridel C; van Gils JHM; Miedema SSM; Hoozemans JJM; Pijnenburg YAL; Smit AB; Rozemuller AJM; Abeln S; Teunissen CE Alzheimers Res Ther; 2023 Mar; 15(1):59. PubMed ID: 36949537 [TBL] [Abstract][Full Text] [Related]
8. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights. Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978 [TBL] [Abstract][Full Text] [Related]
10. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology. Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351 [TBL] [Abstract][Full Text] [Related]
11. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Hartnell IJ; Woodhouse D; Jasper W; Mason L; Marwaha P; Graffeuil M; Lau LC; Norman JL; Chatelet DS; Buee L; Nicoll JAR; Blum D; Dorothee G; Boche D Brain; 2024 Feb; 147(2):590-606. PubMed ID: 37703311 [TBL] [Abstract][Full Text] [Related]
12. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM; Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875 [TBL] [Abstract][Full Text] [Related]
13. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770 [TBL] [Abstract][Full Text] [Related]
14. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology. Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418 [TBL] [Abstract][Full Text] [Related]
15. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies. Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197 [TBL] [Abstract][Full Text] [Related]
16. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes. Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190 [TBL] [Abstract][Full Text] [Related]
17. Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features. Gil MJ; Manzano MS; Cuadrado ML; Fernández C; Góméz E; Matesanz C; Calero M; Rábano A J Alzheimers Dis; 2018; 63(3):1109-1117. PubMed ID: 29758948 [TBL] [Abstract][Full Text] [Related]
18. [Neuropathologic Subtypes of Frontotemporal Lobar Degeneration]. Tada M; Kakita A Brain Nerve; 2018 May; 70(5):501-516. PubMed ID: 29760288 [TBL] [Abstract][Full Text] [Related]
19. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations. Davis SE; Cook AK; Hall JA; Voskobiynyk Y; Carullo NV; Boyle NR; Hakim AR; Anderson KM; Hobdy KP; Pugh DA; Murchison CF; McMeekin LJ; Simmons M; Margolies KA; Cowell RM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Arrant AE Acta Neuropathol Commun; 2023 Apr; 11(1):70. PubMed ID: 37118844 [TBL] [Abstract][Full Text] [Related]
20. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]